Eric Van Cutsem

700 total citations
9 papers, 506 citations indexed

About

Eric Van Cutsem is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Oncology. According to data from OpenAlex, Eric Van Cutsem has authored 9 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Hepatology and 3 papers in Oncology. Recurrent topics in Eric Van Cutsem's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Medical Imaging Techniques and Applications (2 papers). Eric Van Cutsem is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Medical Imaging Techniques and Applications (2 papers). Eric Van Cutsem collaborates with scholars based in Belgium, Netherlands and Sweden. Eric Van Cutsem's co-authors include Lambertus P. van den Heuvel, Joost G.J. Hoenderop, René J.M. Bindels, Jenny van der Wijst, Rob Janssen, Dennis van den Berg, Sabine Tejpar, Wouter M. Tiel Groenestege, Stéphanie Thebault and Nine V.A.M. Knoers and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Eric Van Cutsem

9 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Van Cutsem Belgium 4 152 152 123 118 93 9 506
Katrine B. Whitaker United Kingdom 11 105 0.7× 14 0.1× 89 0.7× 98 0.8× 13 0.1× 24 375
Hajime Shimada Japan 9 103 0.7× 23 0.2× 33 0.3× 21 0.2× 8 0.1× 22 347
Yanli Yan China 8 179 1.2× 5 0.0× 47 0.4× 118 1.0× 13 0.1× 20 479
Osamu Takase Japan 12 71 0.5× 27 0.2× 10 0.1× 49 0.4× 13 0.1× 21 533
Cen Chang China 14 72 0.5× 28 0.2× 17 0.1× 24 0.2× 16 0.2× 37 552
H.G. Beger Germany 8 240 1.6× 13 0.1× 45 0.4× 68 0.6× 19 0.2× 18 458
Yosuke Arai Japan 10 189 1.2× 14 0.1× 50 0.4× 76 0.6× 88 0.9× 23 442
Toshi Sassa Japan 8 76 0.5× 28 0.2× 31 0.3× 42 0.4× 377 4.1× 10 553
Homare Ito Japan 10 122 0.8× 25 0.2× 5 0.0× 191 1.6× 26 0.3× 25 522
Sho Sendo Japan 11 62 0.4× 25 0.2× 9 0.1× 85 0.7× 23 0.2× 37 515

Countries citing papers authored by Eric Van Cutsem

Since Specialization
Citations

This map shows the geographic impact of Eric Van Cutsem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Van Cutsem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Van Cutsem more than expected).

Fields of papers citing papers by Eric Van Cutsem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Van Cutsem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Van Cutsem. The network helps show where Eric Van Cutsem may publish in the future.

Co-authorship network of co-authors of Eric Van Cutsem

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Van Cutsem. A scholar is included among the top collaborators of Eric Van Cutsem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Van Cutsem. Eric Van Cutsem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Plummer, Ruth, Alastair Greystoke, Debashis Sarker, et al.. (2024). A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases. Journal of Hepatocellular Carcinoma. Volume 11. 2033–2047. 2 indexed citations
2.
Groenestege, Wouter M. Tiel, Stéphanie Thebault, Jenny van der Wijst, et al.. (2007). Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. Journal of Clinical Investigation. 117(8). 2260–2267. 256 indexed citations
3.
Cutsem, Eric Van. (2007). Integration of the anti-EGFR agent panitumumab into clinical practice in metastatic colorectal cancer.. PubMed. 5(8). 611–3. 4 indexed citations
4.
Flamen, Patrick, Eric Van Cutsem, & Luc Mortelmans. (2000). A new imaging technique for colorectal cancer: positron emission tomography.. PubMed. 27(5 Suppl 10). 22–9. 3 indexed citations
5.
Flamen, Patrick, Stefan Bourgeois, Martin Hiele, et al.. (2000). Positron emission tomography (PET) compared to EUS & spiral CT in staging of patients with potentially operable esophageal carcinoma. Gastroenterology. 118(4). A256–A256. 1 indexed citations
6.
Evers‐Kiebooms, Gerry, et al.. (1999). Beeldvorming, overdracht van informatie en risico: perceptie in families met Familiale Adenomateuse Polyposis. 27(5). 245–254. 1 indexed citations
7.
Flamen, Patrick, Sigrid Stroobants, Eric Van Cutsem, et al.. (1999). Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d-glucose in Recurrent Colorectal Cancer. Journal of Clinical Oncology. 17(3). 894–894. 177 indexed citations
8.
Rutgeerts, Paul, L Broeckaert, Peter-Paul Willemse, et al.. (1994). Push enteroscopy has a higher yield for the diagnosis of the source of occult bleeding than sonde-type enteroscopy. Acta gastro-enterologica belgica. 57. 3 indexed citations
9.
Fevery, Johan, Eric Van Cutsem, Frederik Nevens, et al.. (1990). Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. Journal of Hepatology. 11(2). 153–158. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026